PENN Medicine Announces New Leadership
for the Abramson Cancer Center
of the University of Pennsylvania
(Philadelphia, PA) — The newly appointed Director of the Abramson
Cancer Center of the University of Pennsylvania, Craig B. Thompson, MD,
has named Caryn Lerman, PhD, Deputy Director, and Joseph
R. Carver, MD, Chief of Staff. The appointments of Lerman, Carver,
and Thompson provide a leadership team that will allow the Abramson Cancer
Center to maintain its position as one of the top five Comprehensive Cancer
Centers in National Cancer Institute funding. Together they will oversee
300 active cancer researchers and 299 full-time Penn physicians and faculty
from eight Schools and 41 Departments across the University involved in
research in cancer prevention, diagnosis, treatment, and survivorship.
They will be responsible for $180 million in grant funding for cancer
research and training, including $83.4 million in NCI funding.
Lerman joined Penn in 2001 as Mary W. Calkins Professor in the Department
of Psychiatry of the School of Medicine and the Annenberg
Public Policy Center. For the last five years, Lerman has served as Director
of the Transdisciplinary Tobacco Use Research Center at Penn and Director
of Cancer Control and Population Sciences in the Abramson Family
Cancer Research Institute, the basic science core of the Abramson
Following graduation from Pennsylvania State University, Lerman received
her Doctorate in Clinical Psychology from USC and undertook clinical training
at the Boston Veterans Administration Medical Center. She served on the
faculty of the Medical College of Pennsylvania and Temple University School
of Medicine. In 1993, Lerman was recruited to the Lombardi Cancer Center
of Georgetown University Medical Center where she directed the Cancer
Control Research Program until she was recruited to Penn. Lerman has been
a member of the Board of Scientific Advisors of the NCI, and the National
Human Genome Research (ELSI) Evaluation and Planning Review Committee.
authored over 200 scientific papers on genetic susceptibility testing
for cancer and nicotine dependence pharmacogenetics, and has received
awards for her scholarship from the National Cancer Institute, the American
Psychological Association and the American Society of Preventive Oncology.
Carver has been a Clinical Professor of Medicine at Penn since 2003. He
currently serves as the Senior Administrative Officer of the Abramson
Family Cancer Research Institute and is a member of the Division of Cardiology.
He will continue to hold both of these positions while serving as the
Chief of Staff of the Abramson Cancer Center.
A graduate of Temple University, Carver undertook his medical training
at Hahnemann University School of Medicine. In the past he has served
on the staffs of Hahnemann, Jeanes Hospital and the American Oncologic
Hospital. For the 10 years prior to joining Penn, Carver served as a Corporate
Medical Director for Aetna U.S. Healthcare.
Carver brings extensive administrative experience to the Abramson Cancer
Center having served on the Board of Directors of numerous for-profit
and non-profit organizations. He has served on the Board of Overseers
of Penn’s Nursing School and recently helped lead the Cancer Cardiovascular
Survivors Guidelines Taskforce for the American Society of Clinical Oncology.
Carver has authored over 75 medical papers and monographs and last year
received the Distinguished Teacher Award in Cardiology from the School
of Medicine. His expertise in the treatment of cardiac disease during
cancer therapy has won him national recognition.
Joining the Abramson Cancer Center's new administrative team is Mr.
Robert F. Wynne. Wynne will join the Center as the Director of
Financial and Administrative Affairs. In this new position, he will provide
financial oversight over the combined activities of the Abramson Cancer
Center and the Department of Cancer Biology. A graduate of Cornell University,
Wynne joins the ACC management team having served previously as the Business
Administrator for the Department of Cancer Biology and the Director of
Fiscal and Administrative Operations in the Abramson Family Cancer Research
Institute. Prior to that he, served as Business Administrator of Hematology/Oncology
in the Department of Medicine.
PENN Medicine is a $2.9 billion enterprise dedicated
to the related missions of medical education, biomedical research, and
high-quality patient care. PENN Medicine consists of the University of
Pennsylvania School of Medicine (founded in 1765 as the nation's first
medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S. News &
World Report's most recent ranking of top research-oriented medical schools.
Supporting 1,400 fulltime faculty and 700 students, the School of Medicine
is recognized worldwide for its superior education and training of the
next generation of physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals,
all of which have received numerous national patient-care honors [Hospital
of the University of Pennsylvania; Pennsylvania Hospital, the nation's first
hospital; and Penn Presbyterian Medical Center]; a faculty practice plan;
a primary-care provider network; two multispecialty satellite facilities;
and home care and hospice.